Keywords: Somatostatin; Receptor; Octreotide; Lanreotide; Pasireotide; Neuroendocrine;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: acromegaly; meta-analysis; network meta-analysis; pasireotide; pegvisomant; pituitary gland;
Keywords: Clinical trial; Neuroendocrine; Pasireotide; SOM230;
Keywords: Cushing's syndrome; Cushing's disease; Ketoconazole; Metyrapone; Mitotane; Etomidate; Cabergoline; Pasireotide;
Keywords: Acromegaly; Cushing; Diabetes; Hyperglycaemia; Pasireotide; Somatostatin;
Keywords: Acromegaly; Somatostatin analogs; Pasireotide; Oral octreotide; Antisense molecules; Botulin neurotoxin;
Keywords: CD, Cushing's disease; CS, Cushing's syndrome; ACTH, adrenocorticotropic hormone; UFC, urinary free cortisol; MRI, magnetic resonance imagingCushing's; Pituitary adenoma; Adrenal; Mifepristone; Cabergoline; Pasireotide
Keywords: Pharmacotherapy; Acromegaly; Somatostatin receptor ligand; Pasireotide;
Keywords: Cushing disease; Medical therapy; Pasireotide; Mifepristone; LCI699; Combination therapies;
Serial follow-up of presurgical treatment using pasireotide long-acting release with or without octreotide long-acting release for naïve active acromegaly
Keywords: acromegaly; pasireotide; preoperative treatment; somatostatin analogue; transsphenoidal adenomectomy
Quantitative analysis of pasireotide (SOM230), a cyclic peptide, in monkey plasma using liquid chromatography in combination with tandem mass spectrometry
Keywords: Pasireotide; SOM230; LC–MS/MS; Quantification; Monkey plasma; SPE; μElution
Neuroendocrine tumours – Medical therapy: Biological
Keywords: somatostatin analogue; octreotide; lanreotide; pasireotide; interferon-α; symptomatic treatment; antiproliferative treatment
An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients
Keywords: Pasireotide; Everolimus; Prostate cancer; Castrate-resistant; Phase II;
Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache
Keywords: Acromegaly; Pasireotide; Headache; Analgesic effect; Somatostatin receptors; Truncated sst5
Osilodrostat (LCI699), a potent 11β-hydroxylase inhibitor, administered in combination with the multireceptor-targeted somatostatin analog pasireotide: A 13-week study in rats
Keywords: ACTH; adrenocorticotropic hormone; GH; growth hormone; HPA; hypothalamic-pituitary-adrenal axis; IGF-1; insulin-like growth factor 1; sc; subcutaneous; sst; somatostatin receptor subtypes; Pasireotide; Somatostatin; LCI699; Osilodrostat; 11β-hydroxyl
Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
Keywords: Pasireotide; Somatostatin analogue; Hyperglycemia; Glucose;
Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor
Keywords: CHO, chinese hamster ovarian cells; GH, growth hormone; GPCR, G-protein coupled receptor; HEK293, human embryonic kidney 293 cells; SS-14, somatostatin-14; sst, somatostatin receptorSomatostatin; Octreotide; Pasireotide; Somatostatin receptor; Internaliza
Pharmacokinetics and Safety of Subcutaneous Pasireotide and Intramuscular Pasireotide Long-acting Release in Chinese Male Healthy Volunteers: A Phase I, Single-center, Open-label, Randomized Study
Keywords: Chinese; healthy volunteers; long-acting release; pasireotide; pharmacokinetics; subcutaneous;
Illuminating somatostatin analog action at neuroendocrine tumor receptors
Keywords: sst receptors; octreotide; lanreotide; pasireotide
New prospects for drug treatment in Cushing disease
Keywords: Cushing disease; Drug treatment; Pasireotide; CabergolineEnfermedad de Cushing; Tratamiento farmacológico; Pasireótida; Cabergolina
Nuevas perspectivas en el tratamiento farmacológico de la enfermedad de Cushing
Keywords: Enfermedad de Cushing; Tratamiento farmacológico; Pasireótida; CabergolinaCushing disease; Drug treatment; Pasireotide; cabergoline
Tolerability and Dose Proportional Pharmacokinetics of Pasireotide Administered as a Single Dose or Two Divided Doses in Healthy Male Volunteers: A Single-Center, Open-Label, Ascending-Dose Study
Keywords: pasireotide; SOM230; tolerability; pharmacokinetics; healthy volunteer
Medical Management of Persistent and Recurrent Cushing Disease
Keywords: Cushing disease; Failed transphenoidal surgery; Recurrent Cushing disease; Somatostatin receptor ligands; Pasireotide; Glucocorticoid receptor antagonist; Mifepristone; Adrenal steroidogenesis inhibitors;
Pasireotide (SOM230): Development, mechanism of action and potential applications
Keywords: Pasireotide; SOM230; Acromegaly; Carcinoid tumors; Cushing's disease
Inhibitory effect of pasireotide and octreotide on lymphocyte activation
Keywords: Pasireotide; Octreotide; Immune system; Lymphocyte; Apoptosis